This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its unique structure, featuring a trifluorophenyl group and a cyclopropane ring, makes it valuable for developing drugs with enhanced metabolic stability and bioavailability. It is often employed in the production of small molecule therapeutics targeting specific biological pathways, particularly in the treatment of neurological disorders, inflammation, and infectious diseases. Additionally, its fluorinated aromatic ring contributes to its use in the design of compounds with improved binding affinity to target proteins, making it a crucial component in medicinal chemistry research and drug discovery.